Getinge AB

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Getinge AB (OTCPK:GNGBF) Q1 2024 Earnings Conference Call April 22, 2024 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Erik Cassel - Danske Bank Rickard Anderkrans - Handelsbanken Kristofer Liljeberg - Carnegie Oliver Reinberg - Kepler Cheuvreux Mattias Vadsten - SEB David Adlington - JPMorgan Robert Davies - Morgan Stanley Patrik Ling - DNB Markets David Johansson - Nordea Markets Robert Davies - Morgan Stanley Operator Welcome to the Getinge Q1 2024 Conference Call. [Operator Instructions] Now I will hand the conference over to the speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.

Getinge AB (GNGBF) Q1 2024 Earnings Call Transcript

Medical equipment maker Getinge reported a smaller-than-expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products.

Medical gear maker Getinge's Q1 core profit beats expectations

Getinge AB's (GNGBF) Q4 2023 Earnings Call Transcript

Swedish medical equipment maker Getinge reported on Thursday a smaller than expected rise in operating profit but unexpectedly raised its annual dividend to shareholders.

Medical gear maker Getinge's Q4 lags, dividend rises

Getinge AB (publ) (OTCPK:GNGBF) Q3 2023 Earnings Conference Call October 23, 2023 4:00 AM ET Company Participants Mattias Perjos - President and Chief Executive Officer Lars Sandstrom - Chief Financial Officer Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Erik Cassel - Danske Bank Mattias Vadsten - SEB Anchal Verma - JPMorgan Aisyah Noor - Morgan Stanley Kristofer Liljeberg - Carnegie Rickard Anderkrans - Handelsbanken Operator Welcome to the Getinge Q3 Report 2023. For the first part of the conference call, the participants will be in listen-only mode.

Getinge AB (publ) (GNGBF) Q3 2023 Earnings Call Transcript

Getinge AB is a Swedish healthcare medical tech company with a $5 billion market cap and leading positions in multiple niches within its target markets. The company has faced headwinds in recent years but offers a clear turnaround opportunity with unique diversification and a stable financial foundation. Getinge's focus on the bioprocessing market, along with recent acquisitions, positions it to compete with larger competitors like Thermo Fisher and Danaher.

Getinge: Turnaround Catalysts To Outperform Healthcare Peers

Getinge AB (publ) (OTCPK:GNGBF) Q2 2023 Earnings Conference Call July 18, 2023 4:00 AM ET Company Participants Mattias Perjos - Chief Executive Officer Lars Sandstrom - Chief Financial Officer Conference Call Participants Rickard Anderkrans - Handelsbanken Mattias Vadsten - SEB Oliver Reinberg - Kepler Cheuvreux Erik Cassel - Danske Bank Robert Davies - Morgan Stanley Kristofer Liljeberg - Carnegie Investment Bank Operator Welcome to the Getinge AB Q2 Presentation for 2023. For the first part of the conference call, the participants will be in listen-only mode.

Getinge AB (publ) (GNGBF) Q2 2023 Earnings Call Transcript

Getinge AB (publ) (GNGBF) Q1 2023 Earnings Call Transcript.

Getinge AB (publ) (GNGBF) Q1 2023 Earnings Call Transcript

Getinge AB (publ) (OTCPK:GNGBF) Q4 2022 Earnings Conference Call February 1, 2023 4:00 AM ET Company Participants Mattias Perjos - President and Chief Executive Officer Lars Sandstrom - Chief Financial Officer Conference Call Participants Erik Cassel - ABG Rickard Anderkrans - Handelsbanken Capital Markets AB Oliver Reinberg - Kepler Cheuvreux Kristofer Liljeberg - Carnegie Robert Davies - Morgan Stanley Victor Forssell - Nordea Markets David Adlington - JPMorgan Chase & Co. Peter Ostling - Pareto Securities Operator Welcome to the Getinge Q4 2022 Earnings Call. All participants will be in a listen-only mode.

Getinge AB (publ) (GNGBF) Q4 2022 Earnings Call Transcript

Getinge AB (OTCPK:GNGBF) Q3 2022 Earnings Conference Call October 19, 2022 4:00 AM ET Company Participants Mattias Perjos - CEO Lars Sandstrom - CFO Conference Call Participants Erik Cassel - ABG Kristofer Liljeberg - Carnegie Victor Forssell - Nordea Oliver Reinberg - Kepler Cheuvreux Peter Ostling - Pareto Securities Rickard Anderkrans - Handelsbanken Ed Ridley-Day - Redburn David Adlington - J.P. Morgan Robert Davies - Morgan Stanley Patrik Ling - DNB Markets Michael Toomey - Jefferies Operator Welcome to the Getinge AB Quarter Three Report 2022.

Getinge AB (GNGBF) Q3 2022 Earnings Call Transcript

Getinge AB (OTCPK:GNGBF) Q2 2022 Earnings Conference Call July 19, 2022 4:00 AM ET Company Participants Lars Sandstrom - Chief Financial Officer Mattias Perjos - Chief Executive Officer Conference Call Participants Erik Cassel - ABG Kristofer Liljeberg - Carnegie Victor Forssell - Nordea Patrick Ling - DNB Rickard Anderkrans - Handelsbanken David Adlington - JPMorgan Operator Good morning, and welcome to the Getinge AB Conference Call. All participants will be in listen-only mode.

Getinge AB (GNGBF) CEO Mattias Perjos on Q2 2022 Results - Earnings Call Transcript

Getinge AB ( OTCPK:GNGBF ) Q1 2022 Results Conference Call April 26, 2022 4:00 AM ET Company Participants Mattias Perjos - CEO Lars Sandstrom - CFO Conference Call Participants Erik Cassel - ABG Rickard Anderkrans - Handelsbanken Karl Noren - Danske Bank Kristofer Liljeberg - Carnegie Victor Forssell - Nordea Oliver Reinberg - Kepler Cheuvreux Edward Ridley - Redburn Craig Mcdowell - JP Morgan Patrik Ling - DNB Markets Peter Ostling - Pareto Securities Virendra Chauhan - AlphaValue Mattias Perjos Thank you very much, operator, and thank you, everyone, for joining today's earnings call. We can start directly with moving to Page number 2, and I will take you through the key takeaways for the quarter.

Getinge AB (GNGBF) CEO Mattias Perjos on Q1 2022 Results - Earnings Call Transcript

Getinge AB's (GNGBF) CEO Mattias Perjos on Q3 2021 Results - Earnings Call Transcript

GETINGE AB (GNGBY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Here's What Could Help GETINGE AB (GNGBY) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, GETINGE AB (GNGBY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

GETINGE AB (GNGBY) is on the Move, Here's Why the Trend Could be Sustainable

Getinge AB (GNGBF) CEO Mattias Perjos on Q4 2020 Results - Earnings Call Transcript.

Getinge AB (GNGBF) CEO Mattias Perjos on Q3 2020 Results - Earnings Call Transcript.

Getinge AB (GNGBF) CEO Mattias Perjos on Q3 2020 Results - Quick Version Earnings Call Transcript

Getinge AB (GNGBF) CEO Mattias Perjos on Q2 2020 Results - Earnings Call Transcript.

Getinge AB (GNGBF) CEO Mattias Perjos on Q1 2020 Results - Earnings Call Transcript

Getinge said it will ramp up production of ventilators for intensive care units, with plans to make 26,000 ventilators this year, due to soaring demand as a result of the COVID-19 pandemic. The medical supplies company produced 10,000 ventilators in 2019.

News for Getinge AB Stock (GNGBY)